Skip to main content
. 2013 Jun;74:26–32. doi: 10.1016/j.curtheres.2012.12.002

Figure 1.

Figure 1

Trends in laboratory parameters with treatment time. (A) Red blood cell (RBC), (B) hemoglobin (Hb), (C) hematocrit (Hct), (D) platelet (PLT), (E) PLTs for septic patients, and (F) PLTs for severe septic patients. P < 0.05 compared with the linezolid treatment group before treatment. P < 0.05 compared with the combined treatment group before treatment. VB6, vitamin B6.